Now accepting international patients, 2026

Access advanced medical
treatment in China before
all options close.

CAR-T cell therapy. Proton and heavy-ion treatment. Stem cell protocols. Boao Lecheng exclusives. We review your pathology and tell you which treatment and which hospital match your specific diagnosis — then coordinate every step from records transfer to discharge summary with a named person you can reach directly.

Submit Your Case Explore Treatments
China Care Health Tours — advanced medical treatment in China
Watch our story
6
Cities with partner hospitals
4
NMPA-approved CAR-T products
80%+
Savings vs. US CAR-T pricing
24h
Case review turnaround
What China Offers That You Cannot Get Elsewhere

Four things only China can give you right now.

01 — Price
NMPA-approved CAR-T at $60K–$90K

Yescarta and Kymriah equivalents, full regulatory approval, GMP manufacturing — at 80% less than the US. India and Thailand have no approved CAR-T. Germany and the UK restrict access to nationals. China is the only country where an international patient can access an approved CAR-T product at a cost that is reachable.

CAR-T pricing and products →
02 — Approved Indications
Indications approved in China that are still trial-only elsewhere

China's Axi-cel covers Mantle Cell Lymphoma and Follicular Lymphoma at approved-product status. Some of these indications remain investigational in the US and EU. If you have been told your diagnosis falls outside the approved label at home, it may sit inside China's approved label.

See all approved indications →
03 — Volume
More CAR-T cases than any Western centre — by a large margin

SYSUCC and Nanfang have administered more CAR-T infusions than most Western institutions combined. Volume translates directly into CRS management experience, cell dosing judgment, and lower complication rates. A hospital doing 20 cases a year cannot match a team doing 300.

View partner hospitals →
04 — Trial Access
200+ active CAR-T trials — open to international patients

Solid tumours, autoimmune disease (SLE, Sjögren's, systemic sclerosis), second-infusion protocols after relapse. No equivalent access exists at this scale anywhere else. If you have been told there are no options left, China's trial landscape is the most complete place to look.

Submit your case for trial screening →
What We Coordinate

Treatments available
through China Care

China leads the world in several treatment categories. These are not experimental alternatives. They are approved protocols and active clinical trials at institutions with more patient volume than most Western centres.

01
CAR-T Cell Therapy
Four NMPA-approved products for B-cell lymphomas, multiple myeloma, and B-ALL. Clinical trials open for autoimmune disease and solid tumours. More active trials than any country globally.
$60K–$90K
vs $400K+ in USA
→
02
Proton and Heavy-Ion Therapy
Precision radiotherapy with significantly reduced side effects. China operates more heavy-ion centres than any other country. Lung, prostate, paediatric brain, head and neck cancers.
$25K–$55K
vs $100K–$150K in USA
→
03
Boao Lecheng Exclusives
China's only special medical zone where imported drugs and devices are approved 1 to 5 years before mainland approval. Includes stem cell therapy for Type 2 Diabetes, unavailable anywhere else in China.
Enquire
China-exclusive access
→
04
Stem Cell Therapy
MSC-based protocols for ALS, Parkinson's, multiple sclerosis, spinal cord injury, heart failure, and diabetic complications. Evidence-based programmes at research hospitals, with honest prognosis communication.
$20K–$40K
Not approved in West
→
05
Executive Health Screening
Full-body MRI, PET-CT, genomic panel, and specialist consultations completed in 2 to 3 days. English reports. Same Siemens and GE equipment as Singapore or Germany, at 70 to 80% lower cost.
$3K–$9K
vs $15K+ in Singapore
→
06
Oncology Surgery and Second Opinion
Multidisciplinary tumour boards at SYSUCC, Nanfang, and Fudan. High-volume surgical teams. International patients accepted with full case documentation review before travel.
$15K–$40K
vs $80K–$200K in USA
→
Find Your Treatment

What condition
are you dealing with?

Select a category to see which treatments China offers, with typical costs and access routes. Not sure? Submit your case and we will advise you directly.

CAR-T Therapy
CAR-T Cell Therapy
Four NMPA-approved products for lymphomas, myeloma, and B-ALL. Trials open for autoimmune diseases including lupus, myositis, and rheumatoid arthritis. More active trials than any country globally.
$60K – $90K Learn more →
Radiation
Proton & Heavy-Ion Therapy
Precision radiotherapy with significantly reduced side effects. China operates more heavy-ion centres than any other country. Lung, prostate, paediatric brain, head and neck cancers.
$25K – $55K Learn more →
Surgery
Oncology Surgery & Second Opinion
Multidisciplinary tumour boards at SYSUCC, Nanfang, and Fudan. High-volume surgical teams. Full case review before travel, with English-language MDT report.
$15K – $40K Learn more →
Stem Cell
Stem Cell Therapy
MSC-based protocols for ALS, Parkinson's, multiple sclerosis, spinal cord injury, and heart failure. Evidence-based programmes at research hospitals with honest prognosis communication.
$20K – $40K Learn more →
Boao Exclusive
Boao Lecheng Zone Access
China's only special medical zone where imported drugs and devices are approved 1–5 years before mainland China. Includes stem cell therapy for Type 2 Diabetes and other treatments unavailable elsewhere.
Enquire for pricing Learn more →
Preventive
Executive Health Screening
Full-body MRI, PET-CT, genomic panel, and specialist consultations completed in 2–3 days. English reports. Same Siemens and GE equipment as Singapore, at 70–80% lower cost.
$3K – $9K Learn more →
No treatments matched. Contact us to discuss your specific condition.
International patient consultation at a China Care partner hospital
How It Works

From your first message
to treatment, handled.

1
Find the right hospital
Not sure where to go? Send us your diagnosis and we will recommend the most appropriate hospital and city. Already have a hospital in mind? Contact us and we will help you engage them directly. We will tell you honestly if China is not the right option for your situation.
Response within 24–72 hours
2
Hospital assessment
Send us your medical records, imaging, and diagnosis. We forward your case to the hospital and obtain their initial assessment — confirming whether they can accept you as a patient and providing a preliminary treatment plan and cost estimate in English. Hospital fee and our facilitation fee are always shown separately.
Within 3–7 days
3
Visa, travel, and logistics
The hospital issues your medical visa invitation letter. We coordinate airport transfer, hospital admission, and interpreter during consultations. We also recommend suitable accommodation options near the treatment centre. Most patients travel with one companion.
2–4 weeks before travel
4
Treatment and ongoing support
We remain your point of contact throughout treatment. On discharge, you receive a full English summary and follow-up protocol for your home physician. We remain available for 90 days after discharge for any questions, and can coordinate remote follow-up with the treating team if needed.
Duration varies by treatment
Patient Cases

Real patients. Real outcomes.

International patients treated at China Care's partner hospitals across Beijing and Guangzhou. Names and identifying details anonymised at patients' request.

CAR-T — Lymphoma
Anonymous M. — Russia
Follicular lymphoma, transformed to DLBCL · Beijing
Outcome 1+ year sustained remission

After exhausting salvage options in Russia, this patient received CD19 CAR-T therapy in Beijing and achieved a durable complete response. He has since described the experience as life-changing on Russian social media.

CAR-T — Lymphoma
David T. — Canada
Diffuse large B-cell lymphoma · Guangzhou
Outcome 14 months sustained remission

"I had been told there were no options left. China Care found a CAR-T trial in Guangzhou within a week. I am now in complete remission, fourteen months later." Treated at SYSUCC.

CAR-T — Myeloma
Anonymous T. — Kazakhstan
Multiple myeloma, 5+ years, multiple relapses · Beijing
Outcome Sustained remission

Local physicians had recommended only palliative care. Following cytoreductive chemotherapy and CAR-T infusion in Beijing, she achieved sustained remission — and was able to attend her son's wedding.

CAR-T — Lymphoma
Omar — Morocco
DLBCL, 6 cycles of chemotherapy failed, age 27 · Beijing
Outcome Complete remission, returned home

A 27-year-old medical doctoral student who had failed six chemotherapy cycles. After tumour debulking surgery and dual-target CAR-T in Beijing, he achieved complete remission. He later wrote of “the humanistic warmth of Chinese hospitals.”

Cases coordinated by China Care at partner hospitals in Beijing and Guangzhou. View all partner hospitals →

Xiaoyue Peng
Xiaoyue Peng
Founder, China Care Health Tours

"When you contact China Care, you are contacting me. I review your case with our specialist team and I will tell you if we cannot help."

I have lived and worked across China, Sweden, Singapore, Macau, and Hong Kong. That experience on both sides — inside China's hospital system and inside the world international patients come from — is what China Care is built on. I kept seeing the same gap: treatments that existed in China, patients who needed them, and no reliable way to connect the two. My role is not clinical. I am a coordinator and advocate: I know which hospitals to trust for which conditions, I know how to read the cost landscape, and I know when to say the answer is not China.

China Care is registered in Hong Kong as Huayou Health Consulting Limited. My fee is fixed and disclosed upfront. Your treatment cost is quoted directly by the hospital — I never add to it or mark it up.

Contact Xiaoyue directly · WhatsApp · Contact form
Oncology ward at Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University Cancer Center, Guangzhou — one of China Care's primary partner hospitals for CAR-T and haematological oncology.
Why China Care

Five reasons patients
choose to work with us.

i
We tell you which hospital — and why.

Not every CAR-T product works for every diagnosis. Relma-cel targets CD19-positive B-cell malignancies. Equecabtagene autoleucel targets BCMA-positive myeloma. The right hospital depends on which product matches your pathology, which team has the highest volume for your specific indication, and whether a clinical trial gives you a better risk-adjusted option than an approved product. We make that call based on your records — not on which hospital pays the highest referral fee.

If you already have a hospital in mind, we contact them first. If not, we review your diagnosis, disease stage, and treatment history and recommend the most appropriate option with transparent reasoning. Our facilitation fee: USD 2,000 for cancer treatment, USD 3,500 for CAR-T or bone marrow transplant — shown as a separate line item from the hospital's treatment cost.

ii
Every partner hospital has been personally visited.

We have met the department heads, reviewed patient outcome data, and evaluated international patient facilities at every hospital in our network. If a hospital did not meet our standard, it is not on our list.

iii
English support from assessment to discharge summary.

Most facilitators stop at admission. Xiaoyue remains present at key consultations and ensures you leave with a complete English discharge summary for your home physician, including DICOM imaging files.

iv
We are honest about what China cannot offer.

We have turned away clients when their best option was at home. If your diagnosis does not match any treatment where China holds a genuine advantage, we will tell you. That willingness to decline is the foundation of the trust we ask you to extend to us.

v
Hong Kong-registered. A legal entity with a verifiable address.

China Care Health Tours operates as Hong Kong Huayou Health Consulting Limited. Unlike anonymous facilitators, we have a registered company, a stated fee structure, and a founder whose name is on this website. You know exactly who you are dealing with.

Patient Experience

"I had been told there were no options left. China Care found a CAR-T trial in Guangzhou within a week. I am now in complete remission, fourteen months later."

David T.
Canada · Diffuse Large B-Cell Lymphoma · Treated at SYSUCC, Guangzhou
Name withheld at patient's request. Direct contact available for verified enquiries.
14mo
Sustained remission
Partner Hospitals
Sun Yat-sen University Cancer Center Nanfang Hospital Beijing GoBroad Hospital Peking Union Medical College Hospital Zhongshan Hospital Fudan Shanghai Ruijin Hospital Guangdong Provincial People's Hospital Boao Super Hospital West China Hospital Beijing 301 Hospital + 40 more hospitals
Treatment Costs

What the same treatment
costs elsewhere.

Figures in USD, based on 2025–2026 private-patient rates. China Care provides itemised estimates for every case at no charge.

Treatment USA Canada Germany Singapore China
CAR-T Cell Therapy (approved product) $400K–$500K $380K–$460K $350K–$430K $320K–$400K $60K–$90K Save 82%
Proton Therapy (prostate, full course) $100K–$150K $80K–$120K $60K–$90K $55K–$85K $25K–$45K Save 70%
Heavy-Ion Therapy Not available Not available $90K–$130K Not available $35K–$55K China-only
Stem Cell Therapy (ALS, Parkinson's) Not approved Not approved Not approved Not approved $20K–$40K China-only
Executive Health Screening (2–3 days) $15K–$25K $12K–$20K $9K–$15K $8K–$15K $3K–$9K Save 75%

Costs are indicative. Final pricing depends on diagnosis, hospital, and treatment protocol. Full cost comparison guide

Cost Estimator

How much could
you save?

Select a treatment and your home country to see the cost difference. Figures are based on 2025–2026 private-patient rates.

Treatment
Your home country

Estimates are indicative. China Care provides a free itemised quote for every case. Full comparison guide →

Select a treatment and country above to see the cost comparison.
Common Questions

What patients
ask us first.

Don't see your question? Ask Xiaoyue directly. Most enquiries receive a personal response within 24 hours.

Is treatment in China safe for international patients?
China's top oncology centres treat more patients annually than most Western institutions, which translates directly into surgical volume and clinical experience. The hospitals in our network are ISO-certified, internationally accredited where applicable, and equipped with the same Siemens, GE, and Varian machines used in Germany or Singapore. We only recommend hospitals we have personally visited and vetted.
How does China Care charge for its services?
We charge a fixed facilitation fee: USD 2,000 for cancer surgery, radiotherapy, or chemotherapy; USD 3,500 for CAR-T cell therapy or bone marrow transplant. Your treatment cost is quoted directly by the hospital and shown as a separate line item — we never add to it or mark it up. No payment is required until you decide to proceed.
Do I need to speak Chinese?
No. Xiaoyue attends key consultations with you as an interpreter and patient advocate. All cost estimates, treatment summaries, and discharge documentation are provided in English. Our partner hospitals all have international patient departments with English-speaking coordinators for day-to-day communication during your stay.
How long does the process take from first contact to treatment?
We review your case within 24–72 hours of submission. Hospital matching and cost estimates typically take 3–5 days. Visa processing for a Chinese medical visa is usually 10–15 business days once you have the hospital invitation letter. For urgent oncology cases, we have managed the full process in under three weeks.
What if China is not the right option for my situation?
We will tell you directly. We have declined to take on cases where the patient's best option was closer to home, and we will do the same for yours. Our long-term reputation depends on honest advice, not on filling hospital beds. The initial case review is always free and carries no obligation.
Can I bring a family member or companion?
Yes, and for most treatments we recommend it. We recommend suitable accommodation near the hospital for you and your companion as part of our standard service. Most of our patients travel with a spouse or adult child.
What happens after I return home?
You receive a complete English discharge summary including DICOM imaging files and a follow-up protocol your home physician can act on. Xiaoyue remains available for 90 days after discharge for any questions, and can coordinate remote follow-up consultations with the treating team if needed.
From the Care Blog

Recent guides

All articles
China vs Singapore for Medical Tourism: Which Is Right for You in 2026?
Medical Insights
China vs Singapore for Medical Tourism: Which Is Right for You in 2026?
China and Singapore are Asia's two most sophisticated medical tourism destinations — but they serve very different patients. Singapore offers…
May 2026
→
 Are Chinese Hospitals Safe for Foreign Patients? Honest Answers to the Questions People Actually Ask
Wellness & Culture
Are Chinese Hospitals Safe for Foreign Patients? Honest Answers to the Questions People Actually Ask
Most concerns about Chinese hospitals come from real incidents — but they apply to a specific segment of the market, not to major…
May 2026
→
 Top 10 Hospitals for CAR-T Cell Therapy in Guangzhou
Medical Insights
Top 10 Hospitals for CAR-T Cell Therapy in Guangzhou
Summary: Guangzhou is home to some of China's most advanced oncology institutions, anchored by the Sun Yat-sen University Cancer Center —…
May 2026
→
Start Here

Ready to explore
your options?

Submit your diagnosis and treatment history. We will review your case and tell you within 24 hours whether treatment in China is a viable path, and which hospitals match your situation. No cost, no obligation.

Submit Your Case WhatsApp Xiaoyue
Free, no-obligation assessment
Response within 24 hours
Honest eligibility advice
HK-registered company